| Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis C Carmona-Rivera, PM Carlucci, E Moore, N Lingampalli, ... Science immunology 2 (10), eaag3358, 2017 | 272 | 2017 |
| Outcomes among HIV-positive patients hospitalized with COVID-19 S Karmen-Tuohy, PM Carlucci, FN Zervou, IM Zacharioudakis, G Rebick, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 85 (1), 6-10, 2020 | 251 | 2020 |
| Characteristics, comorbidities, and outcomes in a multicenter registry of patients with human immunodeficiency virus and coronavirus disease 2019 D Dandachi, G Geiger, MW Montgomery, S Karmen-Tuohy, M Golzy, ... Clinical Infectious Diseases 73 (7), e1964-e1972, 2021 | 233 | 2021 |
| Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus P Mistry, S Nakabo, L O’Neil, RR Goel, K Jiang, C Carmona-Rivera, ... Proceedings of the National Academy of Sciences 116 (50), 25222-25228, 2019 | 215 | 2019 |
| Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients PM Carlucci, T Ahuja, C Petrilli, H Rajagopalan, S Jones, J Rahimian Journal of medical microbiology 69 (10), 1228-1234, 2020 | 172 | 2020 |
| Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus PM Carlucci, MM Purmalek, AK Dey, Y Temesgen-Oyelakin, ... JCI insight 3 (8), 2018 | 164 | 2018 |
| Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus SA Hasni, S Gupta, M Davis, E Poncio, Y Temesgen-Oyelakin, ... Nature communications 12 (1), 3391, 2021 | 151 | 2021 |
| Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa AS Byrd, C Carmona-Rivera, LJ O’Neil, PM Carlucci, C Cisar, ... Science translational medicine 11 (508), eaav5908, 2019 | 138 | 2019 |
| Neutrophil extracellular traps mediate articular cartilage damage and enhance cartilage component immunogenicity in rheumatoid arthritis C Carmona-Rivera, PM Carlucci, RR Goel, E James, SR Brooks, C Rims, ... JCI insight 5 (13), 2020 | 136 | 2020 |
| Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients PM Carlucci, T Ahuja, C Petrilli, H Rajagopalan, S Jones, J Rahimian MedRxiv, 2020 | 99 | 2020 |
| Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome P Mistry, C Carmona-Rivera, AK Ombrello, P Hoffmann, NL Seto, A Jones, ... Annals of the rheumatic diseases 77 (12), 1825-1833, 2018 | 96 | 2018 |
| Leveraging the United States epicenter to provide insights on COVID‐19 in patients with systemic lupus erythematosus R Fernandez‐Ruiz, M Masson, MY Kim, B Myers, RH Haberman, ... Arthritis & Rheumatology 72 (12), 1971-1980, 2020 | 70 | 2020 |
| Safety and tolerability of omalizumab: a randomized clinical trial of humanized anti‐IgE monoclonal antibody in systemic lupus erythematosus S Hasni, S Gupta, M Davis, E Poncio, Y Temesgen‐Oyelakin, E Joyal, ... Arthritis & Rheumatology 71 (7), 1135-1140, 2019 | 62 | 2019 |
| Citrullinated aggrecan epitopes as targets of autoreactive CD 4+ T cells in patients with rheumatoid arthritis C Rims, H Uchtenhagen, MJ Kaplan, C Carmona‐Rivera, P Carlucci, ... Arthritis & Rheumatology 71 (4), 518-528, 2019 | 60 | 2019 |
| Neutrophil extracellular trap-associated carbamylation and histones trigger osteoclast formation in rheumatoid arthritis LJ O'Neil, CB Oliveira, X Wang, M Navarrete, A Barrera-Vargas, ... Annals of the rheumatic diseases 82 (5), 630-638, 2023 | 52 | 2023 |
| Modulation of cardiometabolic disease markers by type I interferon inhibition in systemic lupus erythematosus KA Casey, MA Smith, D Sinibaldi, NL Seto, MP Playford, X Wang, ... Arthritis & Rheumatology 73 (3), 459-471, 2021 | 52 | 2021 |
| RNA externalized by neutrophil extracellular traps promotes inflammatory pathways in endothelial cells LP Blanco, X Wang, PM Carlucci, JJ Torres‐Ruiz, J Romo‐Tena, HW Sun, ... Arthritis & Rheumatology 73 (12), 2282-2292, 2021 | 40 | 2021 |
| Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort A Saxena, A Guttmann, M Masson, MY Kim, RH Haberman, R Castillo, ... The Lancet Rheumatology 3 (8), e585-e594, 2021 | 26 | 2021 |
| Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE MM Purmalek, PM Carlucci, AK Dey, M Sampson, Y Temesgen-Oyelakin, ... Lupus Science & Medicine 6 (1), e000332, 2019 | 22 | 2019 |
| 183 A phase 1B/2A trial of tofacitinib, an oral janus kinase inhibitor, in systemic lupus erythematosus S Hasni, S Gupta, MA Davis, E Poncio, Y Temesgen-Oyelakin, A Biehl, ... Lupus science & medicine 6 (Suppl 1), 2019 | 17 | 2019 |
